Citation: Mf. Drummond, EXPERIMENTAL VERSUS OBSERVATIONAL DATA IN THE ECONOMIC-EVALUATION OF PHARMACEUTICALS, Medical decision making, 18(2), 1998, pp. 12-18
Citation: D. Coyle et al., TRIALS AND TRIBULATIONS - EMERGING ISSUES IN DESIGNING ECONOMIC EVALUATIONS ALONGSIDE CLINICAL-TRIALS, International journal of technology assessment in health care, 14(1), 1998, pp. 135-144
Citation: Mf. Drummond, COST-EFFECTIVENESS IN HEALTH AND MEDICINE - GOLD,MR, SIEGEL,JE, RUSSELL,LB, WEINSTEIN,MC, Health economics, 6(5), 1997, pp. 545-546
Citation: Jvm. Chancellor et al., CONSTRUCTING HEALTH STATE PREFERENCE VALUES FROM DESCRIPTIVE QUALITY-OF-LIFE OUTCOMES - MISSION IMPOSSIBLE, Quality of life research, 6(2), 1997, pp. 159-168
Authors:
OBRIEN BJ
HEYLAND D
RICHARDSON WS
LEVINE M
DRUMMOND MF
Citation: Bj. Obrien et al., USERS GUIDES TO THE MEDICAL LITERATURE .13. HOW TO USE AN ARTICLE ON ECONOMIC-ANALYSIS OF CLINICAL-PRACTICE .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS, JAMA, the journal of the American Medical Association, 277(22), 1997, pp. 1802-1806
Authors:
DRUMMOND MF
RICHARDSON WS
OBRIEN BJ
LEVINE M
HEYLAND D
Citation: Mf. Drummond et al., USERS GUIDES TO THE MEDICAL LITERATURE .13. HOW TO USE AN ARTICLE ON ECONOMIC ANALYSTS OF CLINICAL-PRACTICE .A. ARE THE RESULTS OF THE STUDY VALID, JAMA, the journal of the American Medical Association, 277(19), 1997, pp. 1552-1557
Authors:
HILLMAN AL
BRENNER MK
CAPLAN AL
CAREY J
CHAMPEY Y
CULVER KW
DRUMMOND MF
FREUND DA
HOLMES EW
KELLEY WN
KOLATA G
LEVINE MN
LEVY E
SCHONDELMEYER SW
VELU T
WILSON JM
Citation: Al. Hillman et al., GENE-THERAPY - SOCIOECONOMIC AND ETHICAL ISSUES A ROUND-TABLE DISCUSSION, Human gene therapy, 7(9), 1996, pp. 1139-1144
Citation: Mf. Drummond et To. Jefferson, GUIDELINES FOR AUTHORS AND PEER REVIEWERS OF ECONOMIC SUBMISSIONS TO THE BMJ, BMJ. British medical journal, 313(7052), 1996, pp. 275-283
Citation: Lb. Ellwein et Mf. Drummond, ECONOMIC-ANALYSIS ALONGSIDE CLINICAL-TRIALS - BIAS IN THE ASSESSMENT OF ECONOMIC OUTCOMES, International journal of technology assessment in health care, 12(4), 1996, pp. 691-697
Authors:
MENZIN J
OSTER G
DAVIES L
DRUMMOND MF
GREINER W
LUCIONI C
MEROT JL
VANDERSCHULENBURG JG
SOUETRE E
Citation: J. Menzin et al., A MULTINATIONAL ECONOMIC-EVALUATION OF RHDNASE IN THE TREATMENT OF CYSTIC-FIBROSIS, International journal of technology assessment in health care, 12(1), 1996, pp. 52-61
Authors:
CRUMP BJ
PANTON R
DRUMMOND MF
MARCHMENT M
HAWKES RA
Citation: Bj. Crump et al., TRANSFERRING THE COSTS OF EXPENSIVE TREATMENTS FROM SECONDARY TO PRIMARY-CARE, BMJ. British medical journal, 310(6978), 1995, pp. 509-512
Citation: Bj. Obrien et Mf. Drummond, STATISTICAL VERSUS QUANTITATIVE SIGNIFICANCE IN THE SOCIOECONOMIC EVALUATION OF MEDICINES, PharmacoEconomics, 5(5), 1994, pp. 389-398
Citation: Mf. Drummond, HEALTH ECONOMIC-EVALUATION AND REIMBURSEMENT OF PHARMACEUTICALS, European journal of pharmaceutical sciences, 2(1-2), 1994, pp. 56-56
Authors:
OBRIEN BJ
DRUMMOND MF
LABELLE RJ
WILLAN A
Citation: Bj. Obrien et al., IN SEARCH OF POWER AND SIGNIFICANCE - ISSUES IN THE DESIGN AND ANALYSIS OF STOCHASTIC COST-EFFECTIVENESS STUDIES IN HEALTH-CARE, Medical care, 32(2), 1994, pp. 150-163
Citation: Jm. Mason et al., POPULATION SCREENING FOR ABDOMINAL AORTIC-ANEURYSM - DO THE BENEFITS OUTWEIGH THE COSTS, Journal of public health medicine, 15(2), 1993, pp. 154-160
Citation: Mf. Drummond et al., SELECTION OF END-POINTS IN ECONOMIC EVALUATIONS OF CORONARY-HEART-DISEASE INTERVENTIONS, Medical decision making, 13(3), 1993, pp. 184-190